A Review of Neural Stem Cell Transplant Therapy for Traumatic Spinal Cord Injury

被引:0
作者
Eric Fu
Kyle Wallace
Katherine Grayden
Madeline Kaplan
机构
[1] Georgetown University,Special Master’s in Physiology
[2] Georgetown University School of Medicine,undefined
[3] Georgetown University Medical Center,undefined
关键词
Growth factor cocktail; Axonal regeneration; Polymer scaffolding; Glial scarring; Induced pluripotent stem cells; Graft techniques;
D O I
10.1007/s42399-021-00910-7
中图分类号
学科分类号
摘要
Stem cell transplants, and neural stem cells (NSCs) in particular, hold tremendous potential in recreating axonal relays that bridge traumatic spinal cord injuries (SCIs). While currently there is no standardized transplant methodology, common themes emerge from reviewing recent studies. Current research focuses on injecting NSCs without damaging existing tissue, overcoming common hurdles such as glial scarring, immune reaction, and tumorigenesis and inducing proper differentiation into sensory and motor neurons. Notably, scaffolding holds promise in improving outcomes. Although animal trials have demonstrated NSC ability to improve motor function, human trials are mostly limited to verification of safety instead of efficacy. While controversy and debate surround the use of stem cells, NSCs for SCI merit further exploration.
引用
收藏
页码:1586 / 1592
页数:6
相关论文
共 242 条
[1]  
Lim S(2017)Anxiety and depression in patients with traumatic spinal cord injury: a nationwide population-based cohort study PLoS ONE 12 e0169623-194S
[2]  
Shiue Y(2014)Promotion of survival and differentiation of neural stem cells with fibrin and growth factor cocktails after severe spinal cord injury J Vis Exp 89 e50641-1498
[3]  
Ho C(2017)Type and timing of rehabilitation following acute and subacute spinal cord injury: a systematic review Global Spine J 7 175S-21
[4]  
Yu S(2000)The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury Anesth Analg 91 1493-950.e6
[5]  
Kao P(2010)Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin J Spinal Cord Med 33 16-546
[6]  
Wang J(2018)A first-in-human, phase I study of neural stem cell transplantation for chronic spinal cord injury Cell Stem Cell 22 941-7940
[7]  
Kuo J(2018)Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases BMB Rep 51 545-575
[8]  
Lu P(2019)Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies Stem Cell Res Ther 10 238-203
[9]  
Graham L(2012)Self-renewal and differentiation of reactive astrocyte-derived neural stem/progenitor cells isolated from the cortical peri-infarct area after stroke J Neurosci 32 7926-22
[10]  
Wang Y(2013)Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury Molec Brain 6 3-16830